Mark Leonard

Mark Leonard

Company: Allogene Therapeutics

Job title: VP, Process & Product Development


Mark W. Leonard is Vice President, Process and Product Development at Allogene Therapeutics Inc. In this role, he is responsible for strategy and tactics for end-to-end allogeneic CAR T cell process and analytical development, tech transfer and GMP manufacturing outcomes. Prior to joining Allogene, Mark was Executive Director, Cell and Gene Therapy Technical Development at Pfizer where he led the establishment of the Pharmaceutical Sciences Cell and Gene Therapy (CGT) capability build in response to evolving Research CGT priorities and needs. Mark has 28 years broad experience in mammalian and microbial cell line and process development and characterization, and GMP cell banking at Pfizer, Wyeth and Genetics Institute.


Industry Leaders Fireside Chat: Pipeline Progress: Get Your Questions on the Pipelines of the Leading Allogeneic Developers Answered 9:00 am

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.